They also have access to emerging drugs and therapies for their patients. Currently, a nurse practitioner who believes her patient may benefit from an experimental therapy must refer the patient to a physician prepared as a site investigator. Last fall, the School of Nursing became the first in the nation to offer nurses the opportunity to fill an important new role by offering master's degree-level training in clinical research management. The Clinical Research Management Program is the creation of George H. Turner III, MA, RPh, assistant clinical professor, and Anthony T. Dren, MS, PhD, consulting professor. Together, the two have more than 45 years of experience in drug development.
Students can complete the course either on campus or on-line from anywhere in the country.
In addition to our close colleagues in the School of Medicine, the Duke Health System, and the Duke Clinical Research Institute, we benefited from expertise in the Fuqua School of Business and the Departments of Economics and Biometry.